by Anglia Ruskin University Credit: Pixabay/CC0 Public DomainPromising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe COVID-19. The findings are published in the journal Nature Communications. Professor Justin Stebbing of Anglia Ruskin University (ARU) is...
